Tailored Intervention for Melanoma Patient's Families

May 15, 2014 updated by: Fox Chase Cancer Center
The purpose of the investigators' study is to find the best way to provide information about sun protection and skin cancer detection. The investigators want to see which of two methods most improves sun protection and screening attitudes and practices. The investigators hope to improve these attitudes and practices among people who are at higher risk for melanoma. People at higher risk for melanoma are first degree relatives (mother, father, sibling or child) of people diagnosed with melanoma.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Eligible patients will be contacted to find out whether they have any living first degree relatives that we may contact to discuss their participation in our study.

Eligible first degree relatives (FDRs) will participate in our study as outlined under Interventions.

Study Type

Interventional

Enrollment (Actual)

553

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Florida
      • Tampa, Florida, United States, 33612
        • H. Lee Moffitt Cancer Center & Research Institute
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • University of Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19111-2497
        • Fox Chase Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria - Patients (for referral of FDRs):

  • Newly diagnosed with cutaneous malignant melanoma (CMM) within the past 2 years but more than 3 months prior to being approached
  • Seen at FCCC, FCCC Network, Temple, MCC, or HUP patient clinics
  • Greater than 18 years of age
  • English speaking
  • Able to give meaningful informed consent
  • Does NOT have a first-degree relative with CMM

Inclusion Criteria - FDR (First Degree Relative):

  • Current age of at least 21 years
  • One or more of the following additional risk factors; blonde or red hair; marked freckling on the upper back; history of 3 or more blistering sunburns prior to age 20; 3 or more years of an outdoor summer job as a teenager; Actinic keratosis
  • Able to give informed consent
  • English speaking
  • Has residential phone service
  • No personal history of CMM or non-melanoma skin cancer
  • No personal history of dysplastic nevi

Exclusion Criteria - FDR:

  • 2 or more first degree relatives with CMM
  • Has had a total cutaneous examination (TCE) in the past 3 years AND has done skin self-examination (SSE) more than once in the past year AND has a sun protection habits mean score greater than or equal to 4 (often). We are selecting a set participants who are NOT compliant with TCE and are inconsistent/minimal performers of SSE and sun protection practices.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: 1
Group I
Other: Reading materials and discussions

We will send 3 sets of materials via mail, containing information about melanoma prevention and detection, 1 set each month for 3 months. Materials published by:

  • The American Cancer Society
  • The American Academy of Dermatology
  • The Skin Cancer Foundation

The pamphlets contain information about ways to reduce risk for skin cancer including:

  • Sun protection practices
  • Risk factors for melanoma
  • Information about what melanoma looks like
  • How to do skin self-examinations

There will also be a telephone discussion with a health educator, discussing melanoma and other information contained in the pamphlets.

Other Names:
  • Behavioral
  • Supportive Care Intervention
Other: Reading materials and discussions

We will send 3 separate pamphlets created specifically for participants. We will send 1 pamphlet each month for 3 months. The information in the pamphlets will be based on answers from the first survey. These pamphlets will contain information about:

  • Melanoma and skin cancer protection guidelines
  • The benefits of skin screening practices
  • Ways to protect yourself from the sun

In addition to these pamphlets, there will be a telephone discussion with a health educator to discuss melanoma and other information contained in the pamphlets.

Other Names:
  • Behavioral
  • Supportive Care Intervention
Other: Questionnaires

Both groups will complete 3 surveys; at the beginning, 3 months later, 6 months after the second survey. Each survey will ask about:

  • knowledge of melanoma
  • current and past skin cancer screening practices
  • current and past sun protection practices
  • attitudes about skin cancer and sun protection
  • feelings about relative's melanoma diagnosis and treatment
Other Names:
  • Behavioral
  • Supportive Care Intervention
Other: 2
Group II
Other: Reading materials and discussions

We will send 3 sets of materials via mail, containing information about melanoma prevention and detection, 1 set each month for 3 months. Materials published by:

  • The American Cancer Society
  • The American Academy of Dermatology
  • The Skin Cancer Foundation

The pamphlets contain information about ways to reduce risk for skin cancer including:

  • Sun protection practices
  • Risk factors for melanoma
  • Information about what melanoma looks like
  • How to do skin self-examinations

There will also be a telephone discussion with a health educator, discussing melanoma and other information contained in the pamphlets.

Other Names:
  • Behavioral
  • Supportive Care Intervention
Other: Reading materials and discussions

We will send 3 separate pamphlets created specifically for participants. We will send 1 pamphlet each month for 3 months. The information in the pamphlets will be based on answers from the first survey. These pamphlets will contain information about:

  • Melanoma and skin cancer protection guidelines
  • The benefits of skin screening practices
  • Ways to protect yourself from the sun

In addition to these pamphlets, there will be a telephone discussion with a health educator to discuss melanoma and other information contained in the pamphlets.

Other Names:
  • Behavioral
  • Supportive Care Intervention
Other: Questionnaires

Both groups will complete 3 surveys; at the beginning, 3 months later, 6 months after the second survey. Each survey will ask about:

  • knowledge of melanoma
  • current and past skin cancer screening practices
  • current and past sun protection practices
  • attitudes about skin cancer and sun protection
  • feelings about relative's melanoma diagnosis and treatment
Other Names:
  • Behavioral
  • Supportive Care Intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Impact of generic print and phone counseling vs. tailored print and phone counseling interventions on the engagement in total cutaneous examination (TCE) and self-skin examination (SSE) among first degree relatives (FDRs) at increased risk for CMM.
Time Frame: approximately 9 months per participant
approximately 9 months per participant

Secondary Outcome Measures

Outcome Measure
Time Frame
Determine whether the interventions have an impact on attitudinal factors and whether these attitudinal factors mediate the expected association between the interventions and skin surveillance and sun exposure/protection.
Time Frame: approximately 9 months per participant
approximately 9 months per participant

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fox Chase Cancer Center

Collaborators

National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Sharon L Manne, PhD, Fox Chase Cancer Center
  • Principal Investigator: Paul Jacobsen, Ph.D., H. Lee Moffitt Cancer Center and Research Institute
  • Principal Investigator: Michael Ming, MD, University of Pennsylvania

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2005

Primary Completion (Actual)

May 1, 2011

Study Completion (Actual)

May 1, 2011

Study Registration Dates

First Submitted

December 31, 2008

First Submitted That Met QC Criteria

December 31, 2008

First Posted (Estimate)

January 1, 2009

Study Record Updates

Last Update Posted (Estimate)

May 16, 2014

Last Update Submitted That Met QC Criteria

May 15, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FCCC- 05-805
  • IRB 05-805

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe